{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:09:41Z","timestamp":1779923381576,"version":"3.53.1"},"reference-count":97,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","award":["HC 13 Lympho-C"],"award-info":[{"award-number":["HC 13 Lympho-C"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.beha.2017.02.001","type":"journal-article","created":{"date-parts":[[2017,2,11]],"date-time":"2017-02-11T12:00:15Z","timestamp":1486814415000},"page":"41-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Hepatitis C virus \u2013 Associated marginal zone lymphoma"],"prefix":"10.1016","volume":"30","author":[{"given":"Marine","family":"Armand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Besson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Davi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2017.02.001_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1470-2045(02)00651-4","article-title":"Gastric MALT lymphoma: from aetiology to treatment","volume":"3","author":"Du","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.beha.2017.02.001_bib2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nrgastro.2016.176","article-title":"Global epidemiology and burden of HCV infection and HCV-related disease","volume":"14","author":"Thrift","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"Suppl 5","key":"10.1016\/j.beha.2017.02.001_bib3","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/j.dld.2014.10.005","article-title":"Extrahepatic manifestations of chronic hepatitis C virus infection","volume":"46","author":"Cacoub","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.beha.2017.02.001_bib4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm.3248","article-title":"Understanding the hepatitis C virus life cycle paves the way for highly effective therapies","volume":"19","author":"Scheel","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.beha.2017.02.001_bib5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1365-2141.1994.tb05036.x","article-title":"Hepatitis C virus infection in patients with non-Hodgkin's lymphoma","volume":"88","author":"Ferri","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2017.02.001_bib6","first-page":"351","article-title":"Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia","volume":"10","author":"Luppi","year":"1996","journal-title":"Leukemia"},{"issue":"Suppl 3","key":"10.1016\/j.beha.2017.02.001_bib7","first-page":"516","article-title":"B\u00a0cell malignancy and hepatitis C virus infection","volume":"11","author":"Izumi","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2017.02.001_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1440-1746.2001.02406.x","article-title":"Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma","volume":"16","author":"Kuniyoshi","year":"2001","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.beha.2017.02.001_bib9","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1182\/blood.V93.5.1778","article-title":"Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center","volume":"93","author":"Germanidis","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.02.001_bib10","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1182\/blood-2002-01-0226","article-title":"Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia","volume":"99","author":"Rabkin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.02.001_bib11","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1158\/1055-9965.EPI-06-0308","article-title":"Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies","volume":"15","author":"Dal Maso","year":"2006","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.beha.2017.02.001_bib12","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1053\/j.gastro.2006.09.019","article-title":"Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH","volume":"131","author":"Nieters","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.beha.2017.02.001_bib13","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1001\/jama.297.18.2010","article-title":"Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus","volume":"297","author":"Giordano","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.beha.2017.02.001_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.20205","article-title":"B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review","volume":"111","author":"Negri","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.beha.2017.02.001_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4254\/wjh.v8.i2.107","article-title":"Hepatitis C virus and non-Hodgkin's lymphomas: meta-analysis of epidemiology data and therapy options","volume":"8","author":"Pozzato","year":"2016","journal-title":"World J Hepatol"},{"key":"10.1016\/j.beha.2017.02.001_bib16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cgh.2008.02.011","article-title":"Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium","volume":"6","author":"de Sanjose","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.beha.2017.02.001_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ajh.23889","article-title":"Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study","volume":"90","author":"Michot","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.beha.2017.02.001_bib18","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.2005.01.5016","article-title":"Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs","volume":"24","author":"Besson","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beha.2017.02.001_bib19","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/annonc\/mdl388","article-title":"Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT","volume":"18","author":"Arcaini","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beha.2017.02.001_bib20","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3892\/ijo_00000618","article-title":"Extrahepatic disorders of HCV infection: a distinct entity of B-cell neoplasia?","volume":"36","author":"Libra","year":"2010","journal-title":"Int J Oncol"},{"key":"10.1016\/j.beha.2017.02.001_bib21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1182\/blood-2004-05-1711","article-title":"Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?","volume":"105","author":"Saadoun","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.02.001_bib22","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/annonc\/mdp454","article-title":"Subcutaneous \u201clipoma-like\u201d B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT","volume":"21","author":"Paulli","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beha.2017.02.001_bib23","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","article-title":"Biologic and clinical significance of cryoglobulins. A report of 86 cases","volume":"57","author":"Brouet","year":"1974","journal-title":"Am J Med"},{"key":"10.1016\/j.beha.2017.02.001_bib24","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1056\/NEJM199211193272104","article-title":"A\u00a0role for hepatitis C virus infection in type II cryoglobulinemia","volume":"327","author":"Agnello","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beha.2017.02.001_bib25","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/0016-5085(94)90022-1","article-title":"Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage","volume":"106","author":"Lunel","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.beha.2017.02.001_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2249.1996.d01-639.x","article-title":"Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection","volume":"104","author":"Wong","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.beha.2017.02.001_bib27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jcp.55.1.4","article-title":"Cryoglobulins","volume":"55","author":"Ferri","year":"2002","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.beha.2017.02.001_bib28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","article-title":"Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients","volume":"33","author":"Ferri","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.beha.2017.02.001_bib29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archinte.165.1.101","article-title":"Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias","volume":"165","author":"Monti","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.beha.2017.02.001_bib30","first-page":"79","article-title":"Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative diseases","volume":"28","author":"Gorevic","year":"1991","journal-title":"Semin Hematol"},{"key":"10.1016\/j.beha.2017.02.001_bib31","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0002-9343(94)90132-5","article-title":"Mixed cryoglobulinemia and hepatitis C virus","volume":"96","author":"Cacoub","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.beha.2017.02.001_bib32","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1182\/blood.V92.9.3328.421k04_3328_3337","article-title":"Hepatitis C virus infection involves CD34(+) hematopoietic progenitor cells in hepatitis C virus chronic carriers","volume":"92","author":"Sansonno","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.02.001_bib33","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1002\/art.20594","article-title":"Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection","volume":"50","author":"Vallat","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.beha.2017.02.001_bib34","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2141.1995.tb05582.x","article-title":"Clonal B-cell expansions in peripheral blood of HCV-infected patients","volume":"90","author":"Franzin","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2017.02.001_bib35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection","volume":"347","author":"Hermine","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beha.2017.02.001_bib36","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2036.2005.02395.x","article-title":"Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection","volume":"21","author":"Gisbert","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.beha.2017.02.001_bib37","doi-asserted-by":"crossref","first-page":"638185","DOI":"10.1155\/2012\/638185","article-title":"Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy","volume":"2012","author":"Arcaini","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.beha.2017.02.001_bib38","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1182\/blood-2016-05-714667","article-title":"Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection","volume":"128","author":"Arcaini","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.02.001_bib39","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0140-6736(93)91409-F","article-title":"Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori","volume":"342","author":"Wotherspoon","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.beha.2017.02.001_bib40","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1182\/blood.V91.7.2433","article-title":"Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1\/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas","volume":"91","author":"Ivanovski","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.02.001_bib41","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1182\/blood.V96.10.3578","article-title":"Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia","volume":"96","author":"De Re","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.02.001_bib42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0002-9440(10)61691-4","article-title":"Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma","volume":"159","author":"Marasca","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.beha.2017.02.001_bib43","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.V97.4.1023","article-title":"V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen","volume":"97","author":"Chan","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.02.001_bib44","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.4049\/jimmunol.174.10.6532","article-title":"Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: a model of infection-driven lymphomagenesis","volume":"174","author":"Carbonari","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.beha.2017.02.001_bib45","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1182\/blood-2007-07-101717","article-title":"Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia","volume":"111","author":"Charles","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.02.001_bib46","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1182\/blood.V98.13.3745","article-title":"The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis","volume":"98","author":"Quinn","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.02.001_bib47","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/sj.leu.2404201","article-title":"HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations","volume":"20","author":"De Re","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2017.02.001_bib48","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/jmv.1890450411","article-title":"Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: a new marker of HCV infection closely associated with viremia","volume":"45","author":"Lesniewski","year":"1995","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.beha.2017.02.001_bib49","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/hep.510280429","article-title":"High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C","volume":"28","author":"Ishii","year":"1998","journal-title":"Hepatol"},{"key":"10.1016\/j.beha.2017.02.001_bib50","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.autrev.2007.03.010","article-title":"The pathophysiology of HCV induced B-cell clonal disorders","volume":"6","author":"Landau","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.beha.2017.02.001_bib51","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2013-10-532895","article-title":"B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)-infected patients rarely react with the viral proteins","volume":"123","author":"Ng","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.02.001_bib52","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.virol.2004.11.041","article-title":"Immunoglobulin mimicry by Hepatitis C Virus envelope protein E2","volume":"332","author":"Hu","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.beha.2017.02.001_bib53","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.3324\/haematol.2010.025437","article-title":"Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma","volume":"95","author":"Zibellini","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2017.02.001_bib54","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1084\/jem.20050068","article-title":"Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity","volume":"201","author":"Bende","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.beha.2017.02.001_bib55","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/leu.2011.311","article-title":"Antigen receptor stereotypy across B-cell lymphoproliferations: the case of IGHV4-59\/IGKV3-20 receptors with rheumatoid factor activity","volume":"26","author":"Kostareli","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2017.02.001_bib56","series-title":"ASH 57th annual meeting","article-title":"Auto-immune origin of B Cells from HCV-associated lymphoma [abstract]","author":"Armand","year":"2015"},{"key":"10.1016\/j.beha.2017.02.001_bib57","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.iy.13.040195.001015","article-title":"The CD19\/CR2\/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity","volume":"13","author":"Fearon","year":"1995","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.beha.2017.02.001_bib58","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.beha.2017.02.001_bib59","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"Lindenbach","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.beha.2017.02.001_bib60","doi-asserted-by":"crossref","first-page":"18544","DOI":"10.1073\/pnas.0509402102","article-title":"Activation of na\u00efve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders","volume":"102","author":"Rosa","year":"2005","journal-title":"Proc Natl Acad Sci U. S. A"},{"key":"10.1016\/j.beha.2017.02.001_bib61","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/hep.28842","article-title":"Preferential association of hepatitis C virus with CD19(+) B cells is mediated by complement system","volume":"64","author":"Wang","year":"2016","journal-title":"Hepatol"},{"key":"10.1016\/j.beha.2017.02.001_bib62","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1128\/jvi.69.6.3893-3896.1995","article-title":"Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells","volume":"69","author":"Sakamuro","year":"1995","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.beha.2017.02.001_bib63","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1128\/jvi.70.7.4438-4443.1996","article-title":"Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype","volume":"70","author":"Ray","year":"1996","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.beha.2017.02.001_bib64","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0147-9571(02)00038-3","article-title":"Expression of hepatitis C virus core protein associated with malignant lymphoma in transgenic mice","volume":"26","author":"Ishikawa","year":"2003","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.beha.2017.02.001_bib65","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/j.gastro.2009.03.061","article-title":"Hepatitis C virus and disrupted interferon signaling promote lymphoproliferation via type II CD95 and interleukins","volume":"137","author":"Machida","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.beha.2017.02.001_bib66","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1182\/blood-2010-05-283358","article-title":"Persistent expression of the full genome of hepatitis C virus in B cells induces spontaneous development of B-cell lymphomas in\u00a0vivo","volume":"116","author":"Kasama","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.02.001_bib67","doi-asserted-by":"crossref","first-page":"13882","DOI":"10.1038\/ncomms13882","article-title":"Hepatitis C virus has a genetically determined lymphotropism through co-receptor B7.2","volume":"8","author":"Chen","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.beha.2017.02.001_bib68","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1128\/JVI.77.3.2134-2146.2003","article-title":"Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in\u00a0vivo and in\u00a0vitro: the apoptotic effects of virus infection","volume":"77","author":"Sung","year":"2003","journal-title":"J\u00a0Virol"},{"issue":"Suppl 1","key":"10.1016\/j.beha.2017.02.001_bib69","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S1590-8658(07)80009-0","article-title":"Hepatitis C virus lymphotropism: lessons from a decade of studies","volume":"39","author":"Zignego","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.beha.2017.02.001_bib70","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1182\/blood-2010-06-275818","article-title":"Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities","volume":"117","author":"Marcucci","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.02.001_bib71","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.humimm.2013.08.273","article-title":"Hepatitis C virus (HCV) infection of peripheral blood mononuclear cells in patients with type II cryoglobulinemia","volume":"74","author":"Jab\u0142o\u0144ska","year":"2013","journal-title":"Hum Immunol"},{"key":"10.1016\/j.beha.2017.02.001_bib72","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/1743-422X-10-346","article-title":"Detection of hepatitis C virus (HCV) negative strand RNA and NS3 protein in peripheral blood mononuclear cells (PBMC): CD3+, CD14+ and CD19+","volume":"10","author":"Pawe\u0142czyk","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.beha.2017.02.001_bib73","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1038\/onc.2015.364","article-title":"Hepatitis C virus upregulates B-cell receptor signaling: a novel mechanism for HCV-associated B-cell lymphoproliferative disorders","volume":"35","author":"Dai","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.beha.2017.02.001_bib74","doi-asserted-by":"crossref","first-page":"e0162965","DOI":"10.1371\/journal.pone.0156384","article-title":"In Situ hepatitis C NS3 protein detection is associated with high grade features in hepatitis C-Associated B-Cell non-Hodgkin lymphomas","volume":"11","author":"Canioni","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.beha.2017.02.001_bib75","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1073\/pnas.0303971101","article-title":"Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes","volume":"101","author":"Machida","year":"2004","journal-title":"Proc Natl Acad Sci U. S. A"},{"key":"10.1016\/j.beha.2017.02.001_bib76","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2893.2006.00833.x","article-title":"Somatic hypermutation and mRNA expression levels of the BCL-6 gene in patients with hepatitis C virus-associated lymphoproliferative diseases","volume":"14","author":"Hofmann","year":"2007","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.beha.2017.02.001_bib77","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1128\/JVI.03081-12","article-title":"B\u00a0cells in chronically hepatitis C virus-infected individuals lack a virus-induced mutation signature in the TP53, CTNNB1, and BCL6 genes","volume":"87","author":"Tucci","year":"2013","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.beha.2017.02.001_bib78","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2119\/2006-00020.Wu","article-title":"Effect of hepatitis C virus core protein on the molecular profiling of human B lymphocytes","volume":"12","author":"Wu","year":"2006","journal-title":"Mol Med"},{"key":"10.1016\/j.beha.2017.02.001_bib79","doi-asserted-by":"crossref","first-page":"e91373","DOI":"10.1371\/journal.pone.0091373","article-title":"B-cell-intrinsic hepatitis C virus expression leads to B-cell-lymphomagenesis and induction of NF-\u03baB signalling","volume":"9","author":"Kasama","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.beha.2017.02.001_bib80","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/leu.2012.29","article-title":"Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection","volume":"26","author":"Peveling-Oberhag","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2017.02.001_bib81","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.1128\/JVI.00321-06","article-title":"Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation","volume":"80","author":"Machida","year":"2006","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.beha.2017.02.001_bib82","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1182\/blood.V96.8.2910","article-title":"Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II","volume":"96","author":"Kitay-Cohen","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.02.001_bib83","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2141.2001.02573.x","article-title":"bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection","volume":"112","author":"Zuckerman","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2017.02.001_bib84","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.4049\/jimmunol.173.5.3549","article-title":"Frequent joining of Bcl-2 to a JH6 gene in hepatitis C virus-associated t(14;18)","volume":"173","author":"Sasso","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.beha.2017.02.001_bib85","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/sj.leu.2402968","article-title":"Low frequency of bcl-2 rearrangement in HCV-associated non-Hodgkin's lymphoma tissue","volume":"17","author":"Libra","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2017.02.001_bib86","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/sj.leu.2404872","article-title":"Different genomic imbalances in low- and high-grade HCV-related lymphomas","volume":"22","author":"Matteucci","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2017.02.001_bib87","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1182\/blood.V85.9.2528.bloodjournal8592528","article-title":"Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals","volume":"85","author":"Limpens","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.02.001_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-385991-4.00001-5","article-title":"Early steps of follicular lymphoma pathogenesis","volume":"111","author":"Roulland","year":"2011","journal-title":"Adv Immunol"},{"key":"10.1016\/j.beha.2017.02.001_bib89","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3324\/haematol.2014.116855","article-title":"The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection","volume":"100","author":"Arcaini","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2017.02.001_bib90","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1200\/JCO.2005.06.008","article-title":"Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience","volume":"23","author":"Vallisa","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beha.2017.02.001_bib91","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2009-10-248518","article-title":"Rituximab plus Peg-interferon-alpha\/ribavirin compared with Peg-interferon-alpha\/ribavirin in hepatitis C-related mixed cryoglobulinemia","volume":"116","author":"Saadoun","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2017.02.001_bib92","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/annonc\/mdu166","article-title":"Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi","volume":"25","author":"Arcaini","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beha.2017.02.001_bib93","series-title":"Recommendations for testing, managing, and treating hepatitis C","author":"AASLD-IDSA","year":"2016"},{"key":"10.1016\/j.beha.2017.02.001_bib94","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jvh.12518","article-title":"The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis","volume":"23","author":"Peveling-Oberhag","year":"2016","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.beha.2017.02.001_bib95","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/annonc\/mds643","article-title":"ESMO consensus conferences: guidelines on malignant lymphoma. Part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma","volume":"24","author":"Dreyling","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beha.2017.02.001_bib96","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/ajh.21564","article-title":"Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas","volume":"85","author":"Arcaini","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.beha.2017.02.001_bib97","doi-asserted-by":"crossref","first-page":"e0162965","DOI":"10.1371\/journal.pone.0162965","article-title":"Antiviral treatment of HCV-infected patients with B-Cell non-Hodgkin lymphoma: ANRS HC-13 Lympho-C study","volume":"11","author":"Alric","year":"2016","journal-title":"PloS One"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692617300051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692617300051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T12:35:50Z","timestamp":1719059750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692617300051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":97,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1521692617300051"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2017.02.001","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C virus \u2013 Associated marginal zone lymphoma","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2017.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}